Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Zevra Therapeutics (ZVRA) R&D In Process (2022)

Historic R&D In Process for Zevra Therapeutics (ZVRA) over the last 1 years, with Q2 2022 value amounting to $17.7 million.

  • Zevra Therapeutics' R&D In Process changed N/A to $17.7 million in Q2 2022 from the same period last year, while for Dec 2022 it was $17.7 million, marking a year-over-year change of. This contributed to the annual value of $17.7 million for FY2022, which is N/A changed from last year.
  • Per Zevra Therapeutics' latest filing, its R&D In Process stood at $17.7 million for Q2 2022.
  • Over the past 5 years, Zevra Therapeutics' R&D In Process peaked at $17.7 million during Q2 2022, and registered a low of $17.7 million during Q2 2022.